Global Insulin Pens, Syringes, Pumps, and Injectors Market to Expand to $34.41B by 2028 at 7.9% CAGR, Driven by AI and 3D Imaging

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $34.41 billion In 2028 At A CAGR Of 7.9%:

The insulin pens, syringes, pumps and injectors market size has grown strongly in recent years. It will grow from $23.3 billion in 2023 to $25.36 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rising diabetes prevalence, advancements in insulin delivery, patient preference for convenience, aging population.

The insulin pens, syringes, pumps and injectors market size is expected to see strong growth in the next few years. It will grow to $34.41 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to emerging markets growth, regulatory support and reimbursement, personalized medicine, value-based healthcare. Major trends in the forecast period include artificial intelligence (ai) integration, handheld and wireless ultrasound devices, 3d/4d imaging, fusion imaging.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp

Insulin Pens, Syringes, Pumps And Injectors Market Major Segments
The insulin pens, syringes, pumps and injectors market covered in this report is segmented -
1) By Type: Pens, Injectors And Pumps, Syringes
2) By Pens: Reusable, Disposable
3) By Pumps: Tubed Pumps, Tubeless Pumps
4) By End Users: Hospitals, Homecare, Other End Users

Key Driver - Rising Global Diabetes Prevalence Drives Growth In Insulin Pens, Syringes, Pumps And Injectors Market

An increase in the prevalence of diabetes globally is driving the growth of the insulin pens, syringes, pumps, and injectors market. The increase in the number of people suffering from obesity, unhealthy eating habits, physical inactivity, and the increasing geriatric population are some of the key factors which are leading to the increase in the global prevalence of diabetes. According to the US Centers for Disease Control and Prevention (CDC) in 2020, around 34.2 million people in the U.S. were suffering from diabetes. Also, according to the International Diabetes Federation, in 2021, globally approximately537 million adults were living with diabetes; by 2045, this number would rise to 783 million. Therefore, the increase in the prevalence of diabetes globally is driving the growth of the insulin pens, syringes, pumps, and injectors market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=3806&type=smp

Prominent Trend - FDA Approves Omnipod 5 A Revolutionary Step In Safe And Effective Insulin Delivery

Many companies are focusing on technological advancements in insulin delivery systems to deliver insulin effectively and safely. For instance, in September 2022, the FDA approved the use of Omnipod 5 for children over 2 years with type 1 diabetes. Omnipod is the first tubeless automated insulin delivery aid for people with type 1 diabetes.

Insulin Pens, Syringes, Pumps And Injectors Market Players
Major companies operating in the insulin pens, syringes, pumps and injectors market include Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Insulin Pens, Syringes, Pumps And Injectors Market Report Structure
3. Insulin Pens, Syringes, Pumps And Injectors Market Trends And Strategies
4. Insulin Pens, Syringes, Pumps And Injectors Market - Macro Economic Scenario
5. Insulin Pens, Syringes, Pumps And Injectors Market Size And Growth
…..
27. Insulin Pens, Syringes, Pumps And Injectors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.